[Effect of the procedures of extracorporeal purification of blood on the erythrocyte sodium-lithium countertransporter].
Eliseev
A O
AO
Petrov
V V
VV
Kutsenko
A I
AI
Zaruba
A Iu
AIu
Loginov
V A
VA
Arabidze
G G
GG
Levitskiĭ
D O
DO
Kukharchuk
V V
VV
D017920:Antiporters; D002352:Carrier Proteins / Q000097:blood*; D002908:Chronic Disease; D004912:Erythrocytes / Q000378:metabolism*; D005921:Glomerulonephritis / Q000097:blood / Q000628:therapy; D006464:Hemoperfusion; D006801:Humans; D006929:Hyperaldosteronism / Q000097:blood / Q000628:therapy*; D007674:Kidney Diseases / Q000097:blood / Q000628:therapy*; D052177:Kidney Diseases, Cystic / Q000097:blood / Q000628:therapy; D010956:Plasmapheresis; D011704:Pyelonephritis / Q000097:blood / Q000628:therapy
D017920:Antiporters; D002352:Carrier Proteins; C045885:sodium-lithium countertransporter
Vliianie protsedur ékstrakorporal'nogo ochishcheniia krovi na Na-Li-protivotransport v éritrotsitakh.